LIVE TV
ZEE Business
ZEE BUSINESS
हिंदी में पढ़ें  हिंदी में पढ़ें
Live TV
Live TV
  • Home
  • Budget 2021
  • Personal Finance
    • PPF
    • Mutual Funds
    • Income tax
    • EPFO
    • Income Tax Calculator
    • Personal Loan Calculator
    • Car Loan Calculator
    • Home Loan Calculator
    • SIP calculator
    • SWP Calculator
    • MF Returns Calculator
    • Lumpsum Calculator
  • India
    • Companies
    • Property
    • Startups
    • Uidai
  • Economy
    • Aviation
  • Tech
    • Mobiles
    • Apps
  • Auto
    • Cars
    • Bikes
  • Markets
    • Commodities
    • Currency
  • Jobs
  • Indian Railways
  • World
    • Economy
    • Politics
    • Markets
  • videos
  • photos
  • Authors
  • More ...
    • VIDEOS
    • PHOTOS
Read in App
Business News » World News

Pfizer ends research for new Alzheimer''s, Parkinson's drugs

Pfizer is not making any changes to research and development funding for tanezumab, which is marketed as a treatment for joint pain from osteoarthritis, fibromyalgia treatment Lyrica, or its rare disease program.

  • Twitter
  • Facebook
  • Linkedin
  • whatapp
  • View in App
Pfizer ends research for new Alzheimer''s, Parkinson's drugs
Pfizer Inc is abandoning research to find new drugs aimed at treating Alzheimer`s and Parkinson`s disease. Image source: Reuters
Updated: Mon, Jan 08, 2018
11:08 am
Reuters
RELATED NEWS
Pfizer - Core brands growth to rise, valuation attractive; Anand Rathi upgrades Pfizer to a Buy with a target of Rs 5655 Pfizer - Core brands growth to rise, valuation attractive; Anand Rathi upgrades Pfizer to a Buy with a target of Rs 5655
Big Breaking: Pfizer-BioNTech coronavirus vaccine gets WHO nod for emergency use, says Anil Singhvi Big Breaking: Pfizer-BioNTech coronavirus vaccine gets WHO nod for emergency use, says Anil Singhvi
Exclusive: In 2021, drugmakers to HIKE PRICES as pandemic, political pressure put revenues at risk Exclusive: In 2021, drugmakers to HIKE PRICES as pandemic, political pressure put revenues at risk
Shocking news! Woman tests positive a week after receiving Pfizer COVID-19 vaccine Shocking news! Woman tests positive a week after receiving Pfizer COVID-19 vaccine
Watch: Nurse faints after Pfizer's Covid-19 vaccine allergic reaction on Live TV Watch: Nurse faints after Pfizer's Covid-19 vaccine allergic reaction on Live TV

Pfizer Inc is abandoning research to find new drugs aimed at treating Alzheimer`s and Parkinson`s disease, the U.S. pharmaceutical company announced on Saturday.

The company said it expects to eliminate 300 positions from the neuroscience discovery and early development programs in Andover and Cambridge, Massachusetts, and Groton, Connecticut, as it redistributes the money spent on research, according to the emailed statement.

Pfizer is not making any changes to research and development funding for tanezumab, which is marketed as a treatment for joint pain from osteoarthritis, fibromyalgia treatment Lyrica, or its rare disease program.

"This was an exercise to re-allocate spend across our portfolio, to focus on those areas where our pipeline, and our scientific expertise, is strongest," the company said.

Pfizer has invested heavily in research for Parkinson`s and Alzheimer`s, and is one of several drugmakers, along with GlaxoSmithKline and Eli Lilly, that is part of the Dementia Discovery Fund, a venture capital fund launched in 2015 by industry and government groups that seeks to develop treatments for Alzheimer`s.

However, some of Pfizer`s investments have resulted in disappointment. In 2012, Pfizer and partner Johnson & Johnson called off additional work on the drug bapineuzumab after it failed to help patients with mild to moderate Alzheimer`s in its second round of clinical trials.

The company said on Saturday that it will launch a new venture fund to invest in neuroscience research projects.

Pfizer is expected to make a presentation on Monday at the JP Morgan healthcare conference in San Francisco, a key annual event for healthcare investors.
 

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.

TAGS:
PfizerPfizer IncPfizer researchAlzheimer`sParkinson diseaseUS pharmaceutical companyNeuroscience discoveryPharma
RELATED NEWS
Pfizer - Core brands growth to rise, valuation attractive; Anand Rathi upgrades Pfizer to a Buy with a target of Rs 5655 Pfizer - Core brands growth to rise, valuation attractive; Anand Rathi upgrades Pfizer to a Buy with a target of Rs 5655
Big Breaking: Pfizer-BioNTech coronavirus vaccine gets WHO nod for emergency use, says Anil Singhvi Big Breaking: Pfizer-BioNTech coronavirus vaccine gets WHO nod for emergency use, says Anil Singhvi
Exclusive: In 2021, drugmakers to HIKE PRICES as pandemic, political pressure put revenues at risk Exclusive: In 2021, drugmakers to HIKE PRICES as pandemic, political pressure put revenues at risk
Shocking news! Woman tests positive a week after receiving Pfizer COVID-19 vaccine Shocking news! Woman tests positive a week after receiving Pfizer COVID-19 vaccine
Watch: Nurse faints after Pfizer's Covid-19 vaccine allergic reaction on Live TV Watch: Nurse faints after Pfizer's Covid-19 vaccine allergic reaction on Live TV

LATEST NEWS

IRCTC Share price soars 7% today to over Rs 2000, makes investors extremely happy

7th Pay Commission latest news: REVEALED! Salary may be affected by New Wage Code - know details

Realme GT 5G launched with 64MP triple camera setup and Snapdragon 888 chipset; Check price, India availability and more

Planning to apply for driving licence online? Big convenience! No need to visit RTO office anymore - Here is why

LPG price rising, but gas cylinder booking becomes easier; customers can order refill from three dealers at the same time soon

Exclusive: Jet Airways deal will put country's airports at risk

Stocks to buy with Anil Singhvi: Sandeep Jain recommends VST Tillers Tractors today

Market Guru in talk with RJ Salil Acharya of Radio City: People can invest in infrastructure-related stocks like L&T and Adani ports

Ashok Leyland share price: Sharekhan revises price target to Rs 151

IRCTC share price today hits life-time high of Rs 2015.80; Investors make big money

  • India News
  • World News
  • Companies News
  • Market News
  • Personal Finance News
  • Technology News
  • Automobile News
  • Small Business News
  • Income Tax Calculator
  • Live TV
  • Videos
  • Photos
  • Author
  • Rss Feed
  • Advertise with us
  • Privacy Policy
  • Legal Disclaimer

Latest Trending Updates

  • EPFO
  • Budget 2020
  • Income Tax Return
  • Auto Expo 2020
  • Home Loan
  • Business News

Trending Topics

  • Income Tax
  • income Tax Calculator
  • 7th Pay Commission
  • Reserve Bank of India
  • GST
  • Latest Business News

Follow us on

zeebiz
zeebiz

Partner Sites

  • Zee News
  • Hindi News
  • Marathi News
  • Bengali News
  • Tamil News
  • Malayalam News
  • Gujarati News
  • Telugu News
  • Kannada News
  • DNA
  • WION
Copyright © Zee Media Corporation Ltd. All rights reserved